Teligent Current Ratio 2006-2019 | TLGT

Teligent current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Teligent Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.05B $0.03B 1.46
2018-12-31 $0.05B $0.03B 1.48
2018-09-30 $0.05B $0.04B 1.32
2018-06-30 $0.05B $0.02B 2.75
2018-03-31 $0.05B $0.02B 2.73
2017-12-31 $0.06B $0.02B 3.16
2017-09-30 $0.08B $0.03B 3.16
2017-06-30 $0.10B $0.02B 4.37
2017-03-31 $0.10B $0.02B 5.62
2016-12-31 $0.10B $0.02B 6.90
2016-09-30 $0.11B $0.01B 8.48
2016-06-30 $0.11B $0.01B 8.60
2016-03-31 $0.12B $0.01B 9.08
2015-12-31 $0.12B $0.01B 10.85
2015-09-30 $0.16B $0.01B 17.78
2015-06-30 $0.17B $0.01B 13.11
2015-03-31 $0.18B $0.02B 11.66
2014-12-31 $0.18B $0.01B 13.63
2014-09-30 $0.03B $0.01B 2.90
2014-06-30 $0.01B $0.01B 2.28
2014-03-31 $0.01B $0.00B 2.66
2013-12-31 $0.01B $0.01B 2.02
2013-09-30 $0.01B $0.00B 2.50
2013-06-30 $0.01B $0.00B 2.31
2013-03-31 $0.01B $0.00B 2.52
2012-12-31 $0.01B $0.00B 3.11
2012-09-30 $0.00B $0.00B 3.16
2012-06-30 $0.01B $0.00B 3.17
2012-03-31 $0.01B $0.00B 3.22
2011-12-31 $0.01B $0.00B 4.32
2011-09-30 $0.01B $0.00B 6.05
2011-06-30 $0.01B $0.00B 7.08
2011-03-31 $0.01B $0.00B 6.90
2010-12-31 $0.01B $0.00B 7.91
2010-09-30 $0.00B $0.00B 1.97
2010-06-30 $0.00B $0.00B 2.25
2010-03-31 $0.00B $0.00B 2.67
2009-12-31 $0.00B $0.00B 2.74
2009-09-30 $0.00B $0.00B 3.38
2009-06-30 $0.01B $0.00B 3.56
2009-03-31 $0.01B $0.01B 1.05
2008-12-31 $0.00B $0.00B 0.96
2008-09-30 $0.00B $0.00B 1.24
2008-06-30 $0.00B $0.00B 1.62
2008-03-31 $0.00B $0.00B 2.08
2007-12-31 $0.00B $0.00B 1.69
2007-09-30 $0.00B $0.00B 0.92
2007-06-30 $0.00B $0.00B 0.91
2007-03-31 $0.00B $0.00B 0.98
2006-12-31 $0.00B $0.00B 0.64
2006-09-30 $0.00B $0.00B 0.65
2006-06-30 $0.00B $0.00B 0.58
2006-03-31 $0.00B $0.00B 0.64
2005-12-31 $0.00B $0.00B 0.70
2005-09-30 $0.00B $0.00B 1.46
2005-06-30 $0.00B $0.00B 1.89
2005-03-31 $0.00B $0.00B 1.96
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.035B $0.066B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $42.880B 7.81
Mylan (MYL) United Kingdom $9.443B 4.13
Teva Pharmaceutical Industries (TEVA) Israel $8.593B 3.37
Bausch Health Cos (BHC) Canada $8.382B 5.73
Dr Reddy's Laboratories (RDY) India $5.986B 22.39
Supernus Pharmaceuticals (SUPN) United States $1.616B 16.15
Voyager Therapeutics (VYGR) United States $1.021B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.971B 54.32
Homology Medicines (FIXX) United States $0.854B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.752B 1.12
Akorn (AKRX) United States $0.602B 0.00
CymaBay Therapeutics (CBAY) United States $0.486B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.441B 0.00
Assembly Biosciences (ASMB) United States $0.335B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.281B 0.00
Sol-Gel Technologies (SLGL) Israel $0.175B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.151B 0.00
Acasti Pharma (ACST) Canada $0.079B 0.00
Agile Therapeutics (AGRX) United States $0.063B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.055B 0.00
Evoke Pharma (EVOK) United States $0.014B 0.00
Aevi Genomic Medicine (GNMX) United States $0.013B 0.00